BHCM
MGNX icon

Brevan Howard Capital Management’s MacroGenics MGNX Stock Holding History

Brevan Howard Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92.7K Buy
+32,079
New +$68.4K ﹤0.01% 2041
2024
Q4 		– Sell
-41,706
Closed -$137K – 1285
2024
Q3 		$137K Buy
41,706
+20,184
+94% +$78.6K ﹤0.01% 1046
2024
Q2 		$91.5K Buy
+21,522
New +$210K ﹤0.01% 971

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Brevan Howard Capital Management's MGNX Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in MacroGenics (MGNX) in Q1 2026: 32,079 shares worth $92.7K. The stake represents ﹤0.01% of the portfolio and ranks #2041 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in MGNX as recently as Q3 2024.

Brevan Howard Capital Management first reported a position in MGNX in Q2 2024 and has held it in 3 quarters since. The position peaked at $137K in Q3 2024. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Brevan Howard Capital Management held 32,079 shares of MacroGenics worth $92.7K as of Q1 2026.
  • MacroGenics was a new Brevan Howard Capital Management position in Q1 2026.
  • MacroGenics made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #2041 holding.
  • Brevan Howard Capital Management first reported a position in MacroGenics in Q2 2024 and has held it in 3 quarters since.
  • Brevan Howard Capital Management's MacroGenics position peaked at $137K in Q3 2024.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.